ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Supernus Pharmaceuticals 

1550 East Gude Drive

Rockville  Maryland  20850  U.S.A.
Phone: 301-838-2501 Fax: n/a


SEARCH JOBS



 Key Statistics


Email:
Ownership: Public

Web Site: Supernus Pharmaceuticals
Employees:
Symbol: SUPN
 



Industry
Pharmaceutical






 Company News
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing for Oxtellar XR® 12/10/2014 7:06:46 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing for Trokendi XR® 12/9/2014 10:54:54 AM
Supernus Pharmaceuticals (SUPN) Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR 11/25/2014 7:18:12 AM
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fifth U.S. Patent Protecting Trokendi XR(R) 11/24/2014 1:12:06 PM
Supernus Pharmaceuticals (SUPN) Sues Zydus Pharmaceuticals (USA) Inc. For Infringement Of Trokendi XR(R) Patents 11/24/2014 12:53:42 PM
Supernus Pharmaceuticals (SUPN) Announces Third Quarter 2014 Results 11/12/2014 7:54:47 AM
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fourth U.S. Patent Protecting Trokendi XR® 11/7/2014 7:46:15 AM
Supernus Pharmaceuticals (SUPN) To Present At Two Investor Conferences 11/5/2014 10:10:42 AM
Supernus Pharmaceuticals (SUPN) To Host Third Quarter 2014 Earnings Conference Call 10/30/2014 8:05:53 AM
Supernus Pharmaceuticals (SUPN) Announces Paragraph IV ANDA Filing For Trokendi XR(R) 10/14/2014 8:22:17 AM
123456789